102 related articles for article (PubMed ID: 8989516)
21. Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level.
Iczkowski KA; Bai S; Pantazis CG
Anticancer Res; 2003; 23(4):3129-40. PubMed ID: 12926045
[TBL] [Abstract][Full Text] [Related]
22. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
[TBL] [Abstract][Full Text] [Related]
23. Expression of CD44 variant isoforms in malignant melanoma.
Seiter S; Schadendorf D; Herrmann K; Schneider M; Rösel M; Arch R; Tilgen W; Zöller M
Clin Cancer Res; 1996 Mar; 2(3):447-56. PubMed ID: 9816190
[TBL] [Abstract][Full Text] [Related]
24. Expression and function of FGFs-4, -8, and -9 suggest functional redundancy and repetitive use as epithelial signals during tooth morphogenesis.
Kettunen P; Thesleff I
Dev Dyn; 1998 Mar; 211(3):256-68. PubMed ID: 9520113
[TBL] [Abstract][Full Text] [Related]
25. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
Cannistra SA; DeFranzo B; Niloff J; Ottensmeir C
Clin Cancer Res; 1995 Mar; 1(3):333-42. PubMed ID: 9815989
[TBL] [Abstract][Full Text] [Related]
26. Novel CD44 messenger RNA isoforms in human thyroid and breast tissues feature unusual sequence rearrangements.
Ermak G; Jennings T; Boguniewicz A; Figge J
Clin Cancer Res; 1996 Aug; 2(8):1251-4. PubMed ID: 9816294
[TBL] [Abstract][Full Text] [Related]
27. Neurturin mRNA expression suggests roles in trigeminal innervation of the first branchial arch and in tooth formation.
Luukko K; Saarma M; Thesleff I
Dev Dyn; 1998 Oct; 213(2):207-19. PubMed ID: 9786421
[TBL] [Abstract][Full Text] [Related]
28. Role of hyaluronan and CD44 in in vitro branching morphogenesis of ureteric bud cells.
Pohl M; Sakurai H; Stuart RO; Nigam SK
Dev Biol; 2000 Aug; 224(2):312-25. PubMed ID: 10926769
[TBL] [Abstract][Full Text] [Related]
29. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
30. CD44 isoforms, including the CD44 V3 variant, are expressed on endothelium, suggesting a role for CD44 in the immobilization of growth factors and the regulation of the local immune response.
Koopman G; Taher TE; Mazzucchelli I; Keehnen RM; van der Voort R; Manten-Horst E; Ricevuti G; Pals ST; Das PK
Biochem Biophys Res Commun; 1998 Apr; 245(1):172-6. PubMed ID: 9535803
[TBL] [Abstract][Full Text] [Related]
31. Runx2 mediates FGF signaling from epithelium to mesenchyme during tooth morphogenesis.
Aberg T; Wang XP; Kim JH; Yamashiro T; Bei M; Rice R; Ryoo HM; Thesleff I
Dev Biol; 2004 Jun; 270(1):76-93. PubMed ID: 15136142
[TBL] [Abstract][Full Text] [Related]
32. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM
Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576
[TBL] [Abstract][Full Text] [Related]
33. Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns.
Miyake H; Hara I; Kamidono S; Eto H
J Urol; 2004 Sep; 172(3):1127-9. PubMed ID: 15311055
[TBL] [Abstract][Full Text] [Related]
34. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression.
Li H; Guo L; Li JW; Liu N; Qi R; Liu J
Int J Oncol; 2000 Nov; 17(5):927-32. PubMed ID: 11029494
[TBL] [Abstract][Full Text] [Related]
35. Alternatively spliced CD44 isoforms containing exon v10 promote cellular adhesion through the recognition of chondroitin sulfate-modified CD44.
Chiu RK; Droll A; Dougherty ST; Carpenito C; Cooper DL; Dougherty GJ
Exp Cell Res; 1999 Apr; 248(1):314-21. PubMed ID: 10094837
[TBL] [Abstract][Full Text] [Related]
36. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
37. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression.
Lu D; Tawfik O; Pantazis C; Hobart W; Chapman J; Iczkowski K
Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431
[TBL] [Abstract][Full Text] [Related]
38. CD44 Expression in Benign and Neoplastic Human Prostates.
Dhir R; Gau JT; Krill D; Bastacky S; Bahnson RR; Cooper DL; Becich MJ
Mol Diagn; 1997 Sep; 2(3):197-204. PubMed ID: 10462610
[TBL] [Abstract][Full Text] [Related]
39. Early developmental expression pattern of retinoblastoma tumor suppressor mRNA indicates a role in the epithelial-to-mesenchyme transformation of endocardial cushion cells.
Wagner M; Miles K; Siddiqui MA
Dev Dyn; 2001 Mar; 220(3):198-211. PubMed ID: 11241829
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical localization and expression of the hyaluronan receptor CD44 in the epithelium of the pig oviduct during oestrus.
Tienthai P; Yokoo M; Kimura N; Heldin P; Sato E; Rodriguez-Martinez H
Reproduction; 2003 Jan; 125(1):119-32. PubMed ID: 12622702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
